Re: from IR/Chris

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: from IR/Chris

in response to

Re: from IR/Chris

KayakerBC

posted on Dec 15, 2022 02:03PM

Just putting it out there but is it possible this 6% royalty stream is relatively new and put it in place with expectation of a sale of Zenith Epigentics in the near future

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply